Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction (PCR) assays beyond respiratory infections

10Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We estimated the predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR) for blood, bone, and soft-tissue cultures. The specificities were 88.8%, 88.5%, and 92.7% for all cultures, blood cultures, and bone and soft-tissue cultures respectively, and the negative predictive values were 99.3%, 99.8%, and 92.7% respectively.

Cite

CITATION STYLE

APA

Noeldner, H. M., Bliek, Z. J., Jones, N. E., Prusa, R. D., Wilkinson, M. S., Bushman, A. M., & Rosa, R. (2022). Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction (PCR) assays beyond respiratory infections. In Antimicrobial Stewardship and Healthcare Epidemiology (Vol. 2). Cambridge University Press. https://doi.org/10.1017/ash.2022.256

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free